Increased Risk of Second Cancers After Testicular Cancer Treatment
Author Information
Author(s): S.D. Fossa, F. Langmark, N. Aass, A. Andersen, R. Lothe, A.L. B0rresen
Primary Institution: The Norwegian Radium Hospital
Hypothesis
Does treatment for testicular cancer increase the risk of developing second non-germ cell malignancies?
Conclusion
Patients treated for testicular cancer have a significantly increased risk of developing second non-germ cell malignancies, particularly lung cancer and malignant melanoma.
Supporting Evidence
- 65 patients developed a second cancer, leading to a relative risk of 1.58.
- Extended radiotherapy increased the relative risk to 4.13.
- The excess risks for lung cancer and malignant melanoma were 2.03 and 3.89, respectively.
- Three cases of acute leukaemia were observed more than 5 years after treatment.
Takeaway
If you have testicular cancer and get treated, you might get other types of cancer later, especially lung cancer.
Methodology
The study analyzed cancer incidence in 876 testicular cancer patients treated from 1956 to 1977, comparing observed and expected cancer cases.
Potential Biases
Potential bias due to the retrospective nature of the study and reliance on historical treatment records.
Limitations
The study did not analyze the incidence of subsequent contralateral testicular germ cell tumors due to incomplete data.
Participant Demographics
Patients were primarily male, with a mean age of about 35 years at diagnosis.
Statistical Information
P-Value
p<0.01
Confidence Interval
1.2-2.0
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website